Catheter Precision (VTAK) Receivables - Net (2017 - 2025)
Catheter Precision (VTAK) has disclosed Receivables - Net for 9 consecutive years, with $123000.0 as the latest value for Q3 2025.
- On a quarterly basis, Receivables - Net rose 14.95% to $123000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $123000.0, a 14.95% increase, with the full-year FY2024 number at $70000.0, down 48.91% from a year prior.
- Receivables - Net was $123000.0 for Q3 2025 at Catheter Precision, up from $115000.0 in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $228000.0 in Q2 2021 to a low of $17000.0 in Q3 2021.
- A 5-year average of $94500.0 and a median of $95000.0 in 2024 define the central range for Receivables - Net.
- Peak YoY movement for Receivables - Net: tumbled 96.42% in 2021, then soared 207.69% in 2023.
- Catheter Precision's Receivables - Net stood at $21000.0 in 2021, then grew by 23.81% to $26000.0 in 2022, then skyrocketed by 426.92% to $137000.0 in 2023, then crashed by 48.91% to $70000.0 in 2024, then surged by 75.71% to $123000.0 in 2025.
- Per Business Quant, the three most recent readings for VTAK's Receivables - Net are $123000.0 (Q3 2025), $115000.0 (Q2 2025), and $85000.0 (Q1 2025).